149 related articles for article (PubMed ID: 33548242)
1. MicroRNA-21 regulates right ventricular remodeling secondary to pulmonary arterial pressure overload.
Chang WT; Fisch S; Dangwal S; Mohebali J; Fiedler AG; Chen M; Hsu CH; Yang Y; Qiu Y; Alexander KM; Chen FY; Liao R
J Mol Cell Cardiol; 2021 May; 154():106-114. PubMed ID: 33548242
[TBL] [Abstract][Full Text] [Related]
2. Distinct time courses and mechanics of right ventricular hypertrophy and diastolic stiffening in a male rat model of pulmonary arterial hypertension.
Kwan ED; Vélez-Rendón D; Zhang X; Mu H; Patel M; Pursell E; Stowe J; Valdez-Jasso D
Am J Physiol Heart Circ Physiol; 2021 Oct; 321(4):H702-H715. PubMed ID: 34448637
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the microRNA signature driving adaptive right ventricular hypertrophy in an ovine model of congenital heart disease.
Kameny RJ; He Y; Zhu T; Gong W; Raff GW; Chapin CJ; Datar SA; Boehme JT; Hata A; Fineman JR
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H847-H854. PubMed ID: 29906222
[TBL] [Abstract][Full Text] [Related]
4. Distinct right ventricle remodeling in response to pressure overload in the rat.
Mendes-Ferreira P; Santos-Ribeiro D; Adão R; Maia-Rocha C; Mendes-Ferreira M; Sousa-Mendes C; Leite-Moreira AF; Brás-Silva C
Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H85-95. PubMed ID: 27199115
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary artery banding is a relevant model to study the right ventricular remodeling and dysfunction that occurs in pulmonary arterial hypertension.
Akazawa Y; Okumura K; Ishii R; Slorach C; Hui W; Ide H; Honjo O; Sun M; Kabir G; Connelly K; Friedberg MK
J Appl Physiol (1985); 2020 Aug; 129(2):238-246. PubMed ID: 32644912
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of mesenchymal stem cell delivery via a novel cardiac bioscaffold on right ventricles of pulmonary arterial hypertensive rats.
Schmuck EG; Hacker TA; Schreier DA; Chesler NC; Wang Z
Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1005-H1013. PubMed ID: 30822119
[TBL] [Abstract][Full Text] [Related]
7. Dynamic Changes in miR-21 Regulate Right Ventricular Dysfunction in Congenital Heart Disease-Related Pulmonary Arterial Hypertension.
Chang WT; Wu CC; Lin YW; Shih JY; Chen ZC; Wu SN; Wu CC; Hsu CH
Cells; 2022 Feb; 11(3):. PubMed ID: 35159373
[TBL] [Abstract][Full Text] [Related]
8. Right Ventricular Function After Pulmonary Artery Banding: Adaptive Processes Assessed by CMR and Conductance Catheter Measurements in Sheep.
Gufler H; Niefeldt S; Boltze J; Prietz S; Klopsch C; Wagner S; Vollmar B; Yerebakan C
J Cardiovasc Transl Res; 2019 Oct; 12(5):459-466. PubMed ID: 30847657
[TBL] [Abstract][Full Text] [Related]
9. Ferrostatin-1 Blunts Right Ventricular Hypertrophy and Dysfunction in Pulmonary Arterial Hypertension by Suppressing the HMOX1/GSH Signaling.
Song J; Chen Y; Chen Y; Wang S; Dong Z; Liu X; Li X; Zhang Z; Sun L; Zhong J
J Cardiovasc Transl Res; 2024 Feb; 17(1):183-196. PubMed ID: 37603208
[TBL] [Abstract][Full Text] [Related]
10. Fischer rats exhibit maladaptive structural and molecular right ventricular remodelling in severe pulmonary hypertension: a genetically prone model for right heart failure.
Suen CM; Chaudhary KR; Deng Y; Jiang B; Stewart DJ
Cardiovasc Res; 2019 Mar; 115(4):788-799. PubMed ID: 30357319
[TBL] [Abstract][Full Text] [Related]
11. Galectin-3 levels are associated with right ventricular functional and morphologic changes in pulmonary arterial hypertension.
Fenster BE; Lasalvia L; Schroeder JD; Smyser J; Silveira LJ; Buckner JK; Brown KK
Heart Vessels; 2016 Jun; 31(6):939-46. PubMed ID: 25976729
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-140 is elevated and mitofusin-1 is downregulated in the right ventricle of the Sugen5416/hypoxia/normoxia model of pulmonary arterial hypertension.
Joshi SR; Dhagia V; Gairhe S; Edwards JG; McMurtry IF; Gupte SA
Am J Physiol Heart Circ Physiol; 2016 Sep; 311(3):H689-98. PubMed ID: 27422986
[TBL] [Abstract][Full Text] [Related]
13. Colchicine Depolymerizes Microtubules, Increases Junctophilin-2, and Improves Right Ventricular Function in Experimental Pulmonary Arterial Hypertension.
Prins KW; Tian L; Wu D; Thenappan T; Metzger JM; Archer SL
J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28566298
[TBL] [Abstract][Full Text] [Related]
14. Identification of Long Noncoding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial Hypertension.
Omura J; Habbout K; Shimauchi T; Wu WH; Breuils-Bonnet S; Tremblay E; Martineau S; Nadeau V; Gagnon K; Mazoyer F; Perron J; Potus F; Lin JH; Zafar H; Kiely DG; Lawrie A; Archer SL; Paulin R; Provencher S; Boucherat O; Bonnet S
Circulation; 2020 Oct; 142(15):1464-1484. PubMed ID: 32698630
[TBL] [Abstract][Full Text] [Related]
15. Loss of KCNK3 is a hallmark of RV hypertrophy/dysfunction associated with pulmonary hypertension.
Lambert M; Boet A; Rucker-Martin C; Mendes-Ferreira P; Capuano V; Hatem S; Adão R; Brás-Silva C; Hautefort A; Michel JB; Dorfmuller P; Fadel E; Kotsimbos T; Price L; Jourdon P; Montani D; Humbert M; Perros F; Antigny F
Cardiovasc Res; 2018 May; 114(6):880-893. PubMed ID: 29360952
[TBL] [Abstract][Full Text] [Related]
16. Ultrastructural Changes of the Right Ventricular Myocytes in Pulmonary Arterial Hypertension.
Shults NV; Kanovka SS; Ten Eyck JE; Rybka V; Suzuki YJ
J Am Heart Assoc; 2019 Mar; 8(5):e011227. PubMed ID: 30807241
[TBL] [Abstract][Full Text] [Related]
17. FHL-1 is not involved in pressure overload-induced maladaptive right ventricular remodeling and dysfunction.
Veith C; Neghabian D; Luitel H; Wilhelm J; Egemnazarov B; Muntanjohl C; Fischer JH; Dahal BK; Schermuly RT; Ghofrani HA; Grimminger F; Fink L; Kwapiszewska G; Weissmann N; Sydykov A
Basic Res Cardiol; 2020 Jan; 115(2):17. PubMed ID: 31980934
[TBL] [Abstract][Full Text] [Related]
18. RV pressure overload: from hypertrophy to failure.
van der Bruggen CEE; Tedford RJ; Handoko ML; van der Velden J; de Man FS
Cardiovasc Res; 2017 Oct; 113(12):1423-1432. PubMed ID: 28957530
[TBL] [Abstract][Full Text] [Related]
19. Quercetin, Perillyl Alcohol, and Berberine Ameliorate Right Ventricular Disorders in Experimental Pulmonary Arterial Hypertension: Effects on miR-204, miR-27a, Fibrotic, Apoptotic, and Inflammatory Factors.
Rajabi S; Najafipour H; Jafarinejad-Farsangi S; Joukar S; Beik A; Askaripour M; Jafari E; Safi Z
J Cardiovasc Pharmacol; 2021 Jun; 77(6):777-786. PubMed ID: 34016844
[TBL] [Abstract][Full Text] [Related]
20. Sildenafil prevents and reverses transverse-tubule remodeling and Ca(2+) handling dysfunction in right ventricle failure induced by pulmonary artery hypertension.
Xie YP; Chen B; Sanders P; Guo A; Li Y; Zimmerman K; Wang LC; Weiss RM; Grumbach IM; Anderson ME; Song LS
Hypertension; 2012 Feb; 59(2):355-62. PubMed ID: 22203744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
